Elevance Health Inc (ELV) Stock Price, Trades & News

Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of December 2024. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.

Financial Strength

6/10

Name	Current	Vs Industry
Cash-To-Debt	0.25
Equity-to-Asset	0.36
Debt-to-Equity	0.71
Debt-to-EBITDA	2.87
Interest Coverage	7.14
Piotroski F-Score	4/9	0 1 2 3 4 5 6 7 8 9
Beneish M-Score	-3.24	Manipulator Not Manipulator
WACC vs ROIC		WACC ROIC

Growth Rank

10/10

	Name	Current	Vs Industry		Vs History
	3-Year Revenue Growth Rate	10.6
	3-Year EBITDA Growth Rate	3.2
	3-Year EPS without NRI Growth Rate	8.3
	3-Year FCF Growth Rate	-12.8
	3-Year Book Growth Rate	6.8
	Future 3-5Y EPS without NRI Growth Rate Estimate	11.47
	Future 3-5Y Total Revenue Growth Rate Estimate	8.4

Momentum Rank

2/10

	Name	Current	Vs Industry		Vs History
	5-Day RSI	82.92
	9-Day RSI	68
	14-Day RSI	58.42
	3-1 Month Momentum %	-11.29
	6-1 Month Momentum %	4.05
	12-1 Month Momentum %	-28.19

Liquidity Ratio

	Name	Current	Vs Industry		Vs History

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History
	Dividend Yield %	1.88
	Dividend Payout Ratio	0.19
	3-Year Dividend Growth Rate	13
	Forward Dividend Yield %	1.92
	5-Year Yield-on-Cost %	3.85
	3-Year Average Share Buyback Ratio	2
	Shareholder Yield %	1.27

Profitability Rank

8/10

	Name	Current	Vs Industry		Vs History
	Net Margin %	3.23
	EBITDA Margin %	5.71
	FCF Margin %	2.01
	ROE %	14.06
	ROA %	5.12
	ROIC %	7.78
	3-Year ROIIC %	0.75
	Years of Profitability over Past 10-Year	10
	Moat score	7
	Tariff score	8

GF Value Rank

4/10

	Name	Current	Vs Industry		Vs History
	PE Ratio	13.67
	Forward PE Ratio	10.19
	PE Ratio without NRI	10.21
	Shiller PE Ratio	15.88
	Price-to-Owner-Earnings	25.6
	PEG Ratio	1.16
	PS Ratio	0.46
	PB Ratio	1.86
	Price-to-Tangible-Book	36.87
	Price-to-Free-Cash-Flow	22.07
	Price-to-Operating-Cash-Flow	16.76
	EV-to-EBIT	12.41
	EV-to-Forward-EBIT	10.57
	EV-to-EBITDA	10.71
	EV-to-Forward-EBITDA	9.57
	EV-to-Revenue	0.61
	EV-to-Forward-Revenue	0.58
	EV-to-FCF	30.49
	Price-to-GF-Value	0.61
	Price-to-Projected-FCF	0.61
	Price-to-DCF (Earnings Based)	0.43
	Price-to-DCF (FCF Based)	1.15
	Price-to-Median-PS-Value	0.64
	Price-to-Peter-Lynch-Fair-Value	1.2
	Price-to-Graham-Number	4.09
	Earnings Yield (Greenblatt) %	8.06
	FCF Yield %	4.64
	Forward Rate of Return (Yacktman) %	15.65

GF Value: $578.67

ELV

Warning Signs

Warning! GuruFocus detected 2 Medium warning signs with ELV. Try a 7-Day Free Trial to check it out.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.